Current Ratio of Trevi Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Trevi Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Trevi Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1740%, a 55% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Trevi Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1740% +614% +55% 30 Sep 2025
Q2 2025 1370% -65% -4.5% 30 Jun 2025
Q1 2025 1066% -637% -37% 31 Mar 2025
Q4 2024 1029% -337% -25% 31 Dec 2024
Q3 2024 1126% -52% -4.4% 30 Sep 2024
Q2 2024 1435% +427% +42% 30 Jun 2024
Q1 2024 1704% +920% +117% 31 Mar 2024
Q4 2023 1366% +728% +114% 31 Dec 2023
Q3 2023 1179% +684% +139% 30 Sep 2023
Q2 2023 1008% +658% +188% 30 Jun 2023
Q1 2023 783% +478% +157% 31 Mar 2023
Q4 2022 638% +239% +60% 31 Dec 2022
Q3 2022 494% -28% -5.3% 30 Sep 2022
Q2 2022 350% -339% -49% 30 Jun 2022
Q1 2022 305% -494% -62% 31 Mar 2022
Q4 2021 399% -387% -49% 31 Dec 2021
Q3 2021 522% -329% -39% 30 Sep 2021
Q2 2021 690% -241% -26% 30 Jun 2021
Q1 2021 799% -234% -23% 31 Mar 2021
Q4 2020 787% -235% -23% 31 Dec 2020
Q3 2020 850% -36% -4.1% 30 Sep 2020
Q2 2020 931% 30 Jun 2020
Q1 2020 1033% 31 Mar 2020
Q4 2019 1021% 31 Dec 2019
Q3 2019 886% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.